Medtronic’s $738m deal with insulin maker at risk

12-10-2023

Marisa Woutersen

Medtronic’s $738m deal with insulin maker at risk

JHVEphoto / Shutterstock.com

Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow.


EOFlow, Insulet, Medtronic, insulin, trade secret, US, Masaachusites, US District Court for the District of Massachusetts, acquisition, Flex, South Korea

LSIPR